Similarly, PT2 glioma cells also exhibited enhanced migration and invasion capability when treated with the TROAP overexpression plasmid compared to the empty vector, while attenuated migration was observed following transfection with TROAP siRNA (p < 0.05 Figure 4A–D). This evidence concerns the gene TROAP and central nervous system cancer.